Stephen Cornelissen on 20th Strategic Blood Forum from Australian Red Cross Lifeblood
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”It was wonderful to come together this week with global and local experts from government, clinical practice, industry, and the community for the 20th Strategic Blood Forum, hosted by Australian Red Cross Lifeblood.
The Forum provided a valuable opportunity to share knowledge and explore global trends in blood product supply, demand, policy, and innovation and consider their relevance to Australia. At Lifeblood, we are committed to driving meaningful change for the health and wellbeing of Australians today, tomorrow and well into the future.
A special thank you to our ambassador Michael Klim for sharing his insights as a recipient of the plasma derived product IVIg, along with his partner Michelle who also presented.
Demand is growing for this product, and we are grateful for all our plasma donors.”
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT